A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy
- 1 May 2006
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 367 (9521) , 1495-1502
- https://doi.org/10.1016/s0140-6736(06)68649-2
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort studyThe Lancet, 2005
- Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral TherapyJNCI Journal of the National Cancer Institute, 2005
- Antiretroviral Treatment Regimens and Immune Parameters in the Prevention of Systemic AIDS-Related Non-Hodgkin's LymphomaJournal of Clinical Oncology, 2004
- A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcomaAIDS, 2003
- Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected AdultsJNCI Journal of the National Cancer Institute, 2000
- Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirusNature, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcomaThe Lancet, 1995
- Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's SarcomaScience, 1994
- Disseminated Kaposi's Sarcoma in Homosexual MenAnnals of Internal Medicine, 1982